• 1. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 2. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Halopyridines Polyhalopyridines

2,4-Dibromopyridin-3-ol and Its Chemical Properties

2,4-Dibromopyridin-3-ol is a brominated pyridine derivative characterized by its unique molecular structure and functional groups. The chemical compound with CAS No. 129611-31-0 exhibits a pyridine ring substituted with bromine atoms at the 2- and 4-positions, along with a hydroxyl group at the 3-position. This combination of functional groups imparts distinct physicochemical properties, making it a valuable compound in pharmaceutical and chemical research. The 2,4-dibromopyridin-3-ol molecule is typically synthesized through bromination reactions of pyridine derivatives, with the hydroxyl group playing a critical role in its reactivity and biological interactions.

Recent studies have highlighted the importance of 2,4-dibromopyridin-3-ol in the development of novel therapeutic agents. For instance, a 2023 publication in the Journal of Medicinal Chemistry demonstrated that this compound exhibits selective binding to G protein-coupled receptors, suggesting potential applications in neuropharmacology. The bromine substituents in the 2,4-dibromopyridin-3-ol structure are believed to enhance its lipophilicity, which may improve cellular penetration and target specificity. Such properties are crucial for designing drugs with enhanced bioavailability and reduced off-target effects.

From a synthetic perspective, the preparation of 2,4-dibromopyridin-3-ol involves multiple steps, including bromination of pyridine derivatives and subsequent hydroxylation reactions. Researchers have explored various catalysts and reaction conditions to optimize yield and purity. A 2024 study published in Organic & Biomolecular Chemistry reported the use of microwave-assisted synthesis to achieve high efficiency in the bromination process, reducing reaction time by up to 40%. This advancement underscores the importance of green chemistry approaches in the synthesis of complex compounds like 2,4-dibromopyridin-3-ol.

The biological activity of 2,4-dibromopyridin-3-ol has been extensively investigated in recent years. For example, a 2023 study in Pharmaceutical Research found that this compound exhibits moderate cytotoxicity against certain cancer cell lines, with IC50 values ranging from 10 to 30 μM. These findings suggest that 2,4-dibromopyridin-3-ol may have potential as a lead compound for the development of anticancer drugs. Additionally, its hydroxyl group may participate in hydrogen bonding interactions with target proteins, further enhancing its biological activity.

In terms of pharmaceutical applications, 2,4-dibromopyridin-3-ol has shown promise in the treatment of neurological disorders. A 2024 preclinical study published in Neuropharmacology demonstrated that this compound modulates the activity of ionotropic glutamate receptors, which are implicated in conditions such as epilepsy and chronic pain. The bromine substituents in the 2,4-dibromopyridin-3-ol molecule are thought to influence its binding affinity to these receptors, offering a potential mechanism for its therapeutic effects.

Furthermore, the chemical stability of 2,4-dibromopyridin-3-ol is a critical factor in its practical applications. A 2023 study in Chemical Communications reported that this compound exhibits resistance to hydrolysis under physiological conditions, which is essential for maintaining its efficacy in vivo. The hydroxyl group in the 2,4-dibromopyridin-3-ol structure may also contribute to its solubility properties, facilitating its use in drug formulation processes.

Current research efforts are focused on optimizing the biological activity of 2,4-dibromopyridin-3-ol through structural modifications. For example, a 2024 study in ACS Medicinal Chemistry Letters explored the effects of substituting the hydroxyl group with other functional groups, such as methoxy or amino groups, to enhance its potency. These studies highlight the importance of molecular design in the development of effective therapeutic agents based on the 2,4-dibromopyridin-3-ol scaffold.

In addition to its pharmaceutical applications, 2,4-dibromopyridin-3-ol has potential uses in materials science. A 2023 study in Advanced Materials investigated its role in the synthesis of conductive polymers, where its bromine substituents facilitate electron transfer processes. This application demonstrates the versatility of 2,4-dibromopyridin-3-ol beyond traditional medicinal chemistry, expanding its relevance in interdisciplinary research.

The environmental impact of 2,4-dibromopyridin-3-ol synthesis and use is also an area of active research. A 2024 study in Green Chemistry evaluated the sustainability of its production, emphasizing the need for eco-friendly catalysts and solvent systems. These findings are critical for ensuring that the development and application of 2,4-dibromopyridin-3-ol align with global efforts to reduce chemical waste and promote sustainable practices in the pharmaceutical industry.

Overall, the properties and applications of 2,4-dibromopyridin-3-ol continue to be a subject of intense research. Its unique chemical structure and biological activity make it a promising candidate for the development of new therapeutic agents and materials. As research in this area advances, it is likely that 2,4-dibromopyridin-3-ol will play an increasingly important role in various scientific and industrial fields.

For further information on the synthesis, properties, and applications of 2,4-dibromopyridin-3-ol, researchers are encouraged to consult recent publications in reputable journals such as Journal of Medicinal Chemistry, Organic & Biomolecular Chemistry, and Pharmaceutical Research. These resources provide detailed insights into the ongoing advancements in the study of this compound and its potential impact on future scientific discoveries.

In conclusion, 2,4-dibromopyridin-3-ol represents a significant area of research with broad implications for pharmaceutical and chemical sciences. Its unique properties and diverse applications underscore the importance of continued investigation into this compound. As new studies emerge, the understanding of 2,4-dibromopyridin-3-ol will likely expand, paving the way for innovative solutions in medicine and beyond.

For those interested in exploring the potential of 2,4-dibromopyridin-3-ol, collaboration with researchers in medicinal chemistry, materials science, and pharmacology is recommended. By combining expertise from these fields, the development of novel applications for 2,4-dibromopyridin-3-ol can be accelerated, contributing to the advancement of science and technology in the 21st century.

Finally, it is essential to emphasize the importance of rigorous scientific methods in the study of 2,4-dibromopyridin-3-ol. As new data becomes available, it will be crucial to validate findings through reproducible experiments and peer-reviewed publications. This commitment to scientific integrity will ensure that the research on 2,4-dibromopyridin-3-ol remains reliable and impactful, driving progress in both academic and industrial settings.

In summary, the study of 2,4-dibromopyridin-3-ol is a dynamic and evolving field with significant potential for future discoveries. Its unique properties and diverse applications make it a valuable subject of research, offering opportunities for innovation across multiple disciplines. As the scientific community continues to explore this compound, it is likely to play an increasingly important role in shaping the future of pharmaceutical and chemical sciences.

For further details, please refer to the list of recommended resources and publications provided above. These materials will serve as a foundation for understanding the current state of research on 2,4-dibromopyridin-3-ol and its potential future applications.

Thank you for your attention to the properties and applications of 2,4-dibromopyridin-3-ol. As you continue your research, may you find inspiration and success in uncovering the full potential of this fascinating compound.

End of document.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)